AKRO insider trading
Akero Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
AKRO insider activity at a glance
FilingIQ has scored 884 insider transactions for AKRO since Jun 24, 2019. The most recent filing in our index is dated Dec 9, 2025.
Across the full history, 24 open-market purchases
and 441 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on AKRO insider trades is 59.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest AKRO Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
13F funds holding AKRO
Frequently asked
- How many insider trades does FilingIQ track for AKRO?
- FilingIQ tracks 884 Form 4 insider transactions for AKRO (Akero Therapeutics, Inc.), covering filings from Jun 24, 2019 onwards. 0 of those were filed in the last 90 days.
- Are AKRO insiders net buyers or net sellers?
- Across the full Form 4 history for AKRO, 24 transactions (3%) were open-market purchases and 441 (50%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does AKRO insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
Methodology & sources
Every AKRO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.